These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28100318)

  • 1. [Clinical characteristics of clonal evolution after immunosuppressive therapy in children with severe/very severe aplastic anemia].
    Zhang JL; Liu TF; Chang LX; Chen X; Ren YY; Sun CC; Liu C; An WB; Wan Y; Chen XJ; Yang WY; Wang SC; Guo Y; Zou Y; Chen YM; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jan; 19(1):27-33. PubMed ID: 28100318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The life span of red blood cell in patients with severe/very severe aplastic anemia].
    Ye L; Guo J; Jing LP; Peng GX; Zhou K; Li Y; Li Y; Li JP; Fan HH; Song L; Zhang FK; Zhang L
    Zhonghua Xue Ye Xue Za Zhi; 2018 Feb; 39(2):137-142. PubMed ID: 29562449
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of immunosuppressive therapy for childhood aplastic anemia and its predictive factors].
    Zhao FY; Xu XJ; Song H; Yang SL; Tang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):567-70. PubMed ID: 22898273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified immunosuppressive therapy with porcine antilymphocyte globulin plus delayed cyclosporine A in children with severe aplastic anemia.
    Cui Q; Sha P; Chen H; Shen H; Qin L; Li Z; Wu T; Wang Z
    Int J Hematol; 2018 Jan; 107(1):64-68. PubMed ID: 28900860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of concentration of cyclosporine A on the early response to immunosuppressive therapy in severe aplastic anemia].
    Liang LY; Zhang L; Jing LP; Zhou K; Wang XD; Li Y; Peng GX; Li Y; Li JP; Shi LH; Ye L; Fan HH; Zhang P; Chu YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):766-71. PubMed ID: 22339914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination of rabbit antithymocyte globulin and cyclosporine A as first-line therapy for adult severe aplastic anemia].
    Cao HM; Wang HJ; Zhang L; Jing LP; Zhou K; Yang DL; Li HQ; Liu QG; Yan ZS; Liu YZ; Wu YH; Chu YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):38-42. PubMed ID: 21429400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.
    Scheinberg P; Wu CO; Nunez O; Young NS
    J Pediatr; 2008 Dec; 153(6):814-9. PubMed ID: 18672253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero.
    Liu J; Lu XY; Cheng L; Yang Y; Lin SY; Yin H; Liu XQ; Wu XM; He GS
    Hematology; 2019 Dec; 24(1):492-497. PubMed ID: 31221029
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children.
    Kojima S; Ohara A; Tsuchida M; Kudoh T; Hanada R; Okimoto Y; Kaneko T; Takano T; Ikuta K; Tsukimoto I;
    Blood; 2002 Aug; 100(3):786-90. PubMed ID: 12130487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markedly High Plasma Thrombopoietin (TPO) Level is a Predictor of Poor Response to Immunosuppressive Therapy in Children With Acquired Severe Aplastic Anemia.
    Elmahdi S; Muramatsu H; Narita A; Ismael O; Hama A; Nishio N; Okuno Y; Xu Y; Wang X; Takahashi Y; Kojima S
    Pediatr Blood Cancer; 2016 Apr; 63(4):659-64. PubMed ID: 26575027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study.
    Liu Q; Dong H; Li Y; Shen Y; Hong Y; Chen Y; Liu S; Wu X; Liu W; Hu H; Zhao Y; Lin S; Shen Y; Zhou Y; Ye B; Wu D
    Lipids Health Dis; 2022 Oct; 21(1):93. PubMed ID: 36192750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cohort study of immune and hematopoietic functionality changes in severe aplastic anemia patients treated with immunosuppressive therapy.
    Guan J; Sun Y; Fu R; Wang H; Ruan E; Wang X; Qu W; Wang G; Liu H; Wu Y; Song J; Xing L; Li L; Liu H; Liu C; Shao Z
    Medicine (Baltimore); 2019 Jan; 98(3):e14149. PubMed ID: 30653151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of paroxysmal nocturnal hemoglobinuria clone in immunosuppressive therapy for children with severe aplastic anemia.
    Li J; Zong SY; Yin ZX; Gao YY; Liu LP; Wan Y; Lan Y; Gong XW; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):303-308. PubMed ID: 35351262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis-associated aplastic anaemia: clinical characteristics and immunosuppressive therapy outcomes].
    Yang WR; Jing LP; Zhou K; Peng GX; Li Y; Ye L; Li Y; Li JP; Fan HH; Song L; Zhao X; Yang Y; Zhang FK; Zhang L
    Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):399-404. PubMed ID: 27210875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia.
    Sugimori C; Chuhjo T; Feng X; Yamazaki H; Takami A; Teramura M; Mizoguchi H; Omine M; Nakao S
    Blood; 2006 Feb; 107(4):1308-14. PubMed ID: 16179371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis on malignant clonal hematopoiesis in severe aplastic anemia patients with immunosuppressive therapy].
    Cui N; Fu R; Qu W; Ruan E; Wang X; Wang G; Wu Y; Liu H; Guan J; Song J; Xing L; Li L; Jiang H; Liu H; Wang Y; Liu C; Zhang W; Wang H; Shao Z
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2620-2. PubMed ID: 26711612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia.
    Chen L; Ge M; Huo J; Ren X; Shao Y; Li X; Huang J; Wang M; Nie N; Zhang J; Peng J; Zheng Y
    Front Immunol; 2023; 14():1056381. PubMed ID: 36793734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.